IFF
Get informed when a big investor buys or sells
+ FollowMay 6, 2026 - AI Summary
Overvalued by 86.8% based on the discounted cash flow analysis.
| Market cap | $19.42 Billion |
|---|---|
| Enterprise Value | $25.19 Billion |
| Dividend Yield | $1.60 (2.10%) |
| Earnings per Share | $-1.46 |
| Beta | 0.94 |
| Outstanding Shares | 256,000,000 |
| P/E Ratio | 22.85 |
|---|---|
| PEG | -19.6 |
| Price to Sales | 1.75 |
| Price to Book Ratio | 1.34 |
| Enterprise Value to Revenue | 2.34 |
| Enterprise Value to EBIT | 21.15 |
| Enterprise Value to Net Income | 30 |
| Total Debt to Enterprise | 0.25 |
| Debt to Equity | 0.45 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.3601▲ 50.19% |
|---|---|
| Total Calls | 396,300▼ 53.26% |
| Total Puts | 539,000▼ 25.93% |
Holdings and activity of institutional investors.
| Ownership % | 100.45%▲ 0.51% |
|---|---|
| Total Invested | $18.67B▲ 8.25% |
| Investors Holding | 713▼ 19.00% |
No data
IFF uses Uncommon Sense to create what the world needs. As a collective of unconventional thinkers and creators, the Company puts science and artistry to work to create unique and unexpected scents, tastes, experiences and ingredients for the products its world craves.
Provides critical analysis and scoring for tax legislation, directly influencing corporate tax structures and IFF's overall tax burden and financial planning.
Directly impacts IFF's profitability and global operations through tax policy and international trade agreements (tariffs).
FDA oversight is crucial for ingredients used in food, beverages, and cosmetics, and labor laws directly impact IFF's operational costs and workforce management.
Has direct oversight on antitrust enforcement (affecting potential M&A) and intellectual property protection, both critical for a science-driven company like IFF.
Directly impacts IFF as a chemical manufacturer through environmental regulations (EPA), affecting operational costs, waste management, and compliance.